$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 12 13 14 15 16 17 18 19 19 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
| May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 50,000 | 369,000 | 81,750 | |
| May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 30.13 | 50,000 | 1,506,415 | 1,354 | 51.4 K to 1.4 K (-97.36 %) |
| May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 50,000 | 369,000 | 51,354 | 1.4 K to 51.4 K (+3,692.76 %) |
| May 24 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 23,094 | |
| May 24 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.08 | 5,000 | 155,401 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 24 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 19 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 28,094 | |
| May 19 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 30.44 | 5,000 | 152,201 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 19 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 18 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 4,000 | 17,320 | 33,094 | |
| May 18 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.02 | 4,000 | 124,080 | 88,075 | 92.1 K to 88.1 K (-4.34 %) |
| May 18 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 4,000 | 17,320 | 92,075 | 88.1 K to 92.1 K (+4.54 %) |
| May 17 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 31.02 | 2,500 | 77,547 | 2,500 | 5 K to 2.5 K (-50.00 %) |
| May 16 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | M | 9.18 | 12,500 | 114,750 | 0 | |
| May 16 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Sell | S | 31.65 | 12,500 | 395,598 | 13,550 | 26.1 K to 13.6 K (-47.98 %) |
| May 16 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Buy | M | 9.18 | 12,500 | 114,750 | 26,050 | 13.6 K to 26.1 K (+92.25 %) |
| May 16 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 37,094 | |
| May 16 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.68 | 5,000 | 158,408 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 16 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 13 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 2,906 | 12,583 | 42,094 | |
| May 13 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.21 | 2,906 | 90,686 | 88,075 | 91 K to 88.1 K (-3.19 %) |
| May 13 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 2,906 | 12,583 | 90,981 | 88.1 K to 91 K (+3.30 %) |
| May 12 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 45,000 | |
| May 12 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.51 | 5,000 | 157,567 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 12 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 25,000 | 525,000 | 175,000 | |
| May 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 31.45 | 25,000 | 786,268 | 5,000 | 30 K to 5 K (-83.33 %) |
| May 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 25,000 | 525,000 | 30,000 | 5 K to 30 K (+500.00 %) |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 50,000 | |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 55,000 | |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 30.87 | 5,000 | 154,350 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 30.65 | 5,000 | 153,236 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 10 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 09 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 60,000 | |
| May 09 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 30.20 | 5,000 | 151,001 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 09 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 05 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 65,000 | |
| May 05 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.68 | 5,000 | 158,402 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 05 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 05 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Gift | G | 0.00 | 10,000 | 0 | 798,000 | 808 K to 798 K (-1.24 %) |
| May 03 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| May 03 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 1,250 | 0 | 4,976 | 3.7 K to 5 K (+33.55 %) |
| May 03 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 1,354 | 0 | 4,063 | |
| May 03 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 1,354 | 0 | 12,782 | 11.4 K to 12.8 K (+11.85 %) |
| May 03 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 0.00 | 1,050 | 0 | 1,550 | 500 to 1.6 K (+210.00 %) |
| May 03 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,354 | 0 | 4,063 | |
| May 03 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,354 | 0 | 1,354 | 0 to 1.4 K |
| May 03 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Buy | M | 0.00 | 1,050 | 0 | 13,550 | 12.5 K to 13.6 K (+8.40 %) |
| May 03 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| May 03 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 03 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 0.00 | 1,050 | 0 | 180,523 | 179.5 K to 180.5 K (+0.59 %) |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 4.33 | 5,000 | 21,650 | 70,000 | |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 32.27 | 5,000 | 161,352 | 88,075 | 93.1 K to 88.1 K (-5.37 %) |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 4.33 | 5,000 | 21,650 | 93,075 | 88.1 K to 93.1 K (+5.68 %) |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 0.00 | 1,050 | 0 | 88,075 | 87 K to 88.1 K (+1.21 %) |
| May 03 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Gift | G | 0.00 | 29,741 | 0 | 808,000 | 837.7 K to 808 K (-3.55 %) |
| May 03 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 1,083 | 0 | 3,250 | |
| May 03 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 1,083 | 0 | 4,833 | 3.8 K to 4.8 K (+28.88 %) |
| May 03 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 0.00 | 1,050 | 0 | 73,676 | 72.6 K to 73.7 K (+1.45 %) |
| May 03 2011 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
| May 03 2011 | CPHD | CEPHEID | Brown Thomas D | Director | Buy | M | 0.00 | 1,050 | 0 | 16,902 | 15.9 K to 16.9 K (+6.62 %) |
| May 03 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 1,375 | 0 | 4,125 | |
| May 03 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 1,375 | 0 | 1,375 | 0 to 1.4 K |
| May 02 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| May 02 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 47,600 | 171,836 | 10,800 | |
| May 02 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 5,000 | 0 | 20,208 | 15.2 K to 20.2 K (+32.88 %) |
| May 02 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 32.00 | 47,600 | 1,523,200 | 15,208 | 62.8 K to 15.2 K (-75.79 %) |
| May 02 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 47,600 | 171,836 | 62,808 | 15.2 K to 62.8 K (+312.99 %) |
| Apr 28 2011 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 0.00 | 2,100 | 0 | 2,100 | |
| Apr 28 2011 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 31.49 | 18,750 | 590,438 | 18,750 | |
| Apr 27 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.85 | 1,000 | 31,851 | 837,741 | 838.7 K to 837.7 K (-0.12 %) |
| Apr 27 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
| Apr 27 2011 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | A | 31.85 | 9,375 | 298,594 | 9,375 | |
| Apr 27 2011 | CPHD | CEPHEID | SMITH JOSEPH H | Senior VP, Legal/Bu ... | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Apr 27 2011 | CPHD | CEPHEID | SMITH JOSEPH H | Senior VP, Legal/Bu ... | Option Exercise | A | 31.49 | 36,000 | 1,133,640 | 36,000 | |
| Apr 27 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, Opera ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Apr 27 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, Opera ... | Option Exercise | A | 31.49 | 45,000 | 1,417,050 | 45,000 | |
| Apr 27 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 4,833 | 0 | 4,833 | |
| Apr 27 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 31.49 | 43,500 | 1,369,815 | 43,500 | |
| Apr 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Apr 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | A | 31.49 | 36,000 | 1,133,640 | 36,000 | |
| Apr 27 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 2,400 | 8,664 | 58,400 | |
| Apr 27 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Apr 27 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | A | 31.49 | 180,000 | 5,668,200 | 180,000 | |
| Apr 27 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 32.00 | 2,400 | 76,800 | 15,208 | 17.6 K to 15.2 K (-13.63 %) |
| Apr 27 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 2,400 | 8,664 | 17,608 | 15.2 K to 17.6 K (+15.78 %) |
| Apr 27 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | M | 11.94 | 19,500 | 232,830 | 6,500 | |
| Apr 27 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Apr 27 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | A | 31.49 | 36,000 | 1,133,640 | 36,000 | |
| Apr 27 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Sell | S | 31.94 | 19,500 | 622,830 | 3,750 | 23.3 K to 3.8 K (-83.87 %) |
| Apr 27 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Buy | M | 11.94 | 19,500 | 232,830 | 23,250 | 3.8 K to 23.3 K (+520.00 %) |
| Apr 26 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 50,000 | 180,500 | 60,800 | |
| Apr 26 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 31.50 | 50,000 | 1,575,000 | 15,208 | 65.2 K to 15.2 K (-76.68 %) |
| Apr 26 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 50,000 | 180,500 | 65,208 | 15.2 K to 65.2 K (+328.77 %) |
| Apr 27 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Apr 27 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | A | 31.49 | 36,000 | 1,133,640 | 36,000 | |
| Apr 21 2011 | CPHD | CEPHEID | SMITH JOSEPH H | Senior VP, Legal/Bu ... | Sell | S | 31.50 | 648 | 20,412 | 3,726 | 4.4 K to 3.7 K (-14.81 %) |
| Apr 07 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | M | 9.11 | 60,000 | 546,600 | 0 | |
| Apr 07 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | M | 9.08 | 37,500 | 340,313 | 7,500 | |
| Apr 07 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Sell | S | 29.10 | 97,500 | 2,837,104 | 3,750 | 101.3 K to 3.8 K (-96.30 %) |
| Apr 07 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Buy | M | 9.11 | 60,000 | 546,600 | 101,250 | 41.3 K to 101.3 K (+145.45 %) |
| Apr 07 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Buy | M | 9.08 | 37,500 | 340,313 | 41,250 | 3.8 K to 41.3 K (+1,000.00 %) |
| Apr 05 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | M | 8.43 | 12,500 | 105,375 | 37,500 | |
| Apr 05 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Sell | S | 28.43 | 12,500 | 355,375 | 3,750 | 16.3 K to 3.8 K (-76.92 %) |
| Apr 05 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Buy | M | 8.43 | 12,500 | 105,375 | 16,250 | 3.8 K to 16.3 K (+333.33 %) |
| Mar 08 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Option Exercise | M | 7.35 | 20,000 | 147,000 | 0 | |
| Mar 08 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Sell | S | 27.35 | 20,000 | 547,000 | 3,750 | 23.8 K to 3.8 K (-84.21 %) |
| Mar 08 2011 | CPHD | CEPHEID | Enns Russell | SVP, Chief Regulato ... | Buy | M | 7.35 | 20,000 | 147,000 | 23,750 | 3.8 K to 23.8 K (+533.33 %) |
| Mar 29 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 27.30 | 1,000 | 27,297 | 838,741 | 839.7 K to 838.7 K (-0.12 %) |
| Mar 01 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 26.47 | 1,000 | 26,472 | 839,741 | 840.7 K to 839.7 K (-0.12 %) |
| Feb 28 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Option Exercise | M | 8.43 | 2,500 | 21,075 | 22,500 | |
| Feb 28 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Sell | S | 26.43 | 2,500 | 66,075 | 0 | 2.5 K to 0 (-100.00 %) |
| Feb 28 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Buy | M | 8.43 | 2,500 | 21,075 | 2,500 | 0 to 2.5 K |
| Feb 22 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 7.35 | 7,500 | 55,125 | 0 | |
| Feb 22 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Sell | S | 24.82 | 7,500 | 186,164 | 500 | 8 K to 500 (-93.75 %) |
| Feb 22 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 7.35 | 7,500 | 55,125 | 8,000 | 500 to 8 K (+1,500.00 %) |
| Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 131,750 | |
| Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 25.35 | 10,000 | 253,457 | 0 | 10 K to 0 (-100.00 %) |
| Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
| Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 141,750 | |
| Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.53 | 10,000 | 245,344 | 0 | 10 K to 0 (-100.00 %) |
| Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
| Feb 15 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Option Exercise | M | 8.43 | 2,500 | 21,075 | 25,000 | |
| Feb 15 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Sell | S | 25.43 | 2,500 | 63,575 | 0 | 2.5 K to 0 (-100.00 %) |
| Feb 15 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Buy | M | 8.43 | 2,500 | 21,075 | 2,500 | 0 to 2.5 K |
| Feb 14 2011 | CPHD | CEPHEID | MROZ MITCHELL D | Director | Grant | A | 24.87 | 472 | 11,739 | 4,625 | 4.2 K to 4.6 K (+11.37 %) |
| Feb 14 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 24.87 | 648 | 16,116 | 179,473 | 178.8 K to 179.5 K (+0.36 %) |
| Feb 14 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 24.87 | 216 | 5,372 | 72,626 | 72.4 K to 72.6 K (+0.30 %) |
| Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 151,750 | |
| Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 161,750 | |
| Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.73 | 10,000 | 247,266 | 0 | 10 K to 0 (-100.00 %) |
| Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
| Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.51 | 10,000 | 245,081 | 0 | 10 K to 0 (-100.00 %) |